Development of genome-guided immunotherapeutic strategies for head neck cancer

Head neck squamous cell carcinoma (HNSCC) is common and aggressive cancer without effective therapy. Here, we will investigate the functional impact of genomic mutations on anti-tumor immune response in HNSCC, using both animal models and patient-derived tumor organoids. Our work holds the promise to discover novel immunotherapeutic targets and predictive biomarkers for this cancer.